SUBSCRIBE
SUBSCRIBE

Sound Pharmaceuticals

IN THE PRESS
Drug Development
Sound Pharma advances pivotal Phase 3 clinical trials in Meniere’s Disease
June 8, 2020
 · 
4 min read
Drug Development
Sound Pharmaceuticals announces positive topline results from the SPI-1005 Phase 2b Meniere’s Disease clinical trial
June 25, 2019
 · 
6 min read
Drug Development
Sound Pharmaceuticals announces completion of patient enrollment in the Phase 2b Meniere’s Disease clinical trial
March 6, 2019
 · 
2 min read
Drug Development
Sound Pharmaceuticals advances Phase 2 hearing loss clinical trial in Cystic Fibrosis
January 14, 2019
 · 
2 min read
Drug Development
University of Oxford and Sound Pharma Begin Phase II Clinical Trial on Novel Treatment for Bipolar Disorder
November 1, 2017
 · 
2 min read
Drug Development
Sound Pharmaceuticals, Inc. Announces Positive Phase Ib Results And The Start Of A Phase IIb Clinical Trial In Meniere’s Disease
October 4, 2017
 · 
2 min read
BioForest
Sound Pharmaceuticals, Inc. Initiates STOP Ototoxicity Study In Cystic Fibrosis
September 26, 2017
 · 
2 min read
Drug Development
Sound Pharmaceuticals, Inc. Completes Enrollment On Meniere’s Disease Clinical Trial
June 27, 2017
 · 
2 min read
BioForest
Sound Pharmaceuticals, Inc. Announces $1.6 Million Award From Cystic Fibrosis Foundation Therapeutics, Inc. To Prevent And Treat The Hearing Loss And Tinnitus Associated With Antibiotic Use
March 21, 2017
 · 
2 min read
Business
Sound Pharmaceuticals, Inc. Announces Two New Executive Hires To Accelerate Its Meniere’s Drug Development Program
November 1, 2016
 · 
2 min read
Load More
JOBS